Loading clinical trials...
Loading clinical trials...
A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Conditions
Interventions
MACI
microfracture
Locations
12
United States
Stanford University
Palo Alto, California, United States
Shriner's Hospital for Children Northern California
Sacramento, California, United States
University of California Davis Health
Sacramento, California, United States
Ochsner Sports Medicine Institute
New Orleans, Louisiana, United States
Johns Hopkins Outpatient Center
Baltimore, Maryland, United States
University of Michigan
Ann Arbor, Michigan, United States
Start Date
October 24, 2018
Primary Completion Date
June 1, 2027
Completion Date
June 1, 2027
Last Updated
December 2, 2024
NCT06915233
NCT03909139
NCT06915363
NCT06003101
NCT04840147
NCT04364334
Lead Sponsor
Vericel Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions